Učitavanje...
ALK mutation and inhibition in lung cancer
The advent of precision medicine in non-small cell lung cancer has remarkably altered the direction of research and improved clinical outcomes. The identification of molecular subsets with differential response to targeted therapies began with the identification of epidermal growth factor receptor m...
Spremljeno u:
| Izdano u: | Semin Cancer Biol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5316306/ https://ncbi.nlm.nih.gov/pubmed/27637426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2016.08.007 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|